Position in CDNA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$24,567
New position
Shares Held
862
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#188
of 225 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Nykredit A/S holds $199,425,561 across 26 Diagnostics & Research names. CDNA ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
115,085 | $57,699,015 | |
| 2 | DHR |
Danaher Corp /De/
|
171,773 | $32,719,321 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
42,653 | $22,454,245 | |
| 4 | NTRA |
Natera, Inc.
|
57,455 | $15,596,159 | |
| 5 | WAT |
Waters Corp /De/
|
38,061 | $14,274,397 | |
| 6 | ILMN |
Illumina, Inc.
|
64,667 | $11,370,398 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
56,868 | $10,988,034 | |
| 8 | A |
Agilent Technologies, Inc.
|
70,199 | $9,324,533 |
All Filings in CDNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,567 | 862 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||